IPO’s Comments to China’s NMPA on the “Implementation Measures for the Protection of Drug Trial Data” and the “Working Procedures for the Protection of Drug Trial Data.”
IPO’s Comments to China’s NMPA on the "Implementation Measures for [...]
IPO’s Comments to China’s NMPA on the "Implementation Measures for [...]
IPO Request to Testify and Hearing Statement re: World Intellectual [...]
RESOLVED, that IPO supports reversal of the summary judgment opinion [...]
IPO Comments to Indian Patent Office on Draft Guidelines for [...]
IPO Comments to USPTO on WIPO Treaty on IP, Genetic [...]
Harnessing the Power of AI in Patent Searching & Analysis
IPO Comments on “Artificial Intelligence Action Plan”
IPO Post-Hearing Statement to Special 301 Subcommittee